|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 5/02 | |
| C07K 7/02 |
| (11) | Patento numeris | 3327027 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17201829.3 |
| Europos patento paraiškos padavimo data | 2012-11-07 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-05-30 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-01-06 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201161561255 P | 2011-11-17 | US | |
| 201261676423 P | 2012-07-27 | US |
| (72) |
DOROSKI, Matthew David, US
MADERNA, Andreas, US
O`DONNELL, Christopher John, US
SUBRAMANYAM, Chakrapani, US
VETELINO, Beth Cooper, US
DUSHIN, Russell George, US
STROP, Pavel, US
GRAZIANI, Edmund, Idris, US
|
| (73) |
Pfizer Inc.,
235 East 42nd Street, New York, NY 10017,
US
|
| (54) | CYTOTOXIC PEPTIDES AND ANTIBODY DRUG CONJUGATES THEREOF |
| CYTOTOXIC PEPTIDES AND ANTIBODY DRUG CONJUGATES THEREOF |